| Bioactivity | Antitumor agent-125 (compound 17A) is a novel platinum(IV) prodrug. Antitumor agent-125 can activate the mitochondrion-dependent apoptosis pathway. Antitumor agent-125 induces ferroptosis in HCT-116/OXA[1]. |
| Name | Antitumor agent-125 |
| Formula | C27H33ClN4O9Pt |
| Molar Mass | 788.11 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhikun Liu, et al. Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis. Eur J Med Chem. 2024. |
Antitumor agent-125
CAS: F: C27H33ClN4O9Pt W: 788.11
Antitumor agent-125 (compound 17A) is a novel platinum(IV) prodrug. Antitumor agent-125 can activate the mitochondrion-d
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.